Tandem Diabetes Care Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Tandem Diabetes (TNDM) Misses Q1 EPS by 11c
April 27, 2017 4:26 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.75), $0.11 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $15.72 million.
Our first quarter results were highlighted by our sales performance, recognition of our #1 customer... More
